Skystar Bio-Pharmaceutical Co. is a holding company, which engages in the research, development, production, distribution, and sale of veterinary healthcare and medical care products. It operates through the following product lines includes micro-organism, veterinary medicine, feed additives, and bio-pharmaceutical veterinary vaccine. The company was founded was founded on July 3, 1997 and is headquartered in Xi'an, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Skystar Bio-Pharmaceutical Company?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Skystar Bio-Pharmaceutical Company market cap is N/A.
What is the 52-week high for Skystar Bio-Pharmaceutical Company?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Skystar Bio-Pharmaceutical Company 52 week high is N/A as of September 18, 2025.
What is the 52-week low for Skystar Bio-Pharmaceutical Company?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Skystar Bio-Pharmaceutical Company 52 week low is N/A as of September 18, 2025.
What is the PE ratio of Skystar Bio-Pharmaceutical Company?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Skystar Bio-Pharmaceutical Company’s P/E ratio is None.
What is the Price-to-Book ratio of Skystar Bio-Pharmaceutical Company?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Skystar Bio-Pharmaceutical Company P/B ratio is None.
What is Skystar Bio-Pharmaceutical Company's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Skystar Bio-Pharmaceutical Company's EBITDA is N/A.
What is the 50-day moving average of Skystar Bio-Pharmaceutical Company?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Skystar Bio-Pharmaceutical Company 50-day moving average is N/A.
How many employess does Skystar Bio-Pharmaceutical Company has?
Skystar Bio-Pharmaceutical Company has N/A employees.